Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds
Venkata V V R Marada1, Saskia Flörl2, Annett Kühne2
1Institut für Vegetative Physiologie und Pathophysiologie, Universitätsmedizin Göttingen, Humboldtallee 23, 37073 Göttingen, Germany.
Abstract:
Antineoplastic compounds are used in the treatment of a variety of cancers. The effectiveness of an antineoplastic compound to exert its activity is largely dependent on transport proteins involved in the entry of the compound into the cells, and those which drive it out of the cell. Organic anion transporting polypeptide 1B1 (OATP1B1) and organic anion transporting polypeptide 1B3 (OATP1B3), belonging to the SLCO family of proteins, are specifically expressed in the sinusoidal membranes of the liver, and are known to interact with a variety of drugs. The present study deals with the interaction of these proteins with antineoplastic compounds routinely used in cancer chemotherapy. The proteins OATP1B1 and OATP1B3 were functionally characterized in stably transfected human embryonic kidney cells using [(3)H] labeled estrone 3-sulfate and [(3)H] labeled cholecystokinin octapeptide (CCK-8) as substrates, respectively. Substrate uptake experiments performed in the presence of antineoplastic compounds showed that vinblastine and paclitaxel strongly interacted with the OATP1B1 with Ki values of 10.2 μM and 0.84 μM, respectively. OATP1B3 showed highly significant interactions with a variety of antineoplastic compounds including chlorambucil, mitoxantrone, vinblastine, vincristine, paclitaxel and etoposide, with Ki values of 40.6 μM, 3.2 μM, 15.9 μM, 30.6 μM, 1.8 μM and 13.5 μM, respectively. We report several novel interactions of the transporter proteins OATP1B1 and OATP1B3 highlighting the need to investigate their role in drug-drug interactions and cancer chemotherapy.
Insights
This study reveals how cancer drugs interact with liver transport proteins Organic Anion Transporting Polypeptide 1B1 (OATP1B1) and OATP1B3. Understanding these interactions is crucial for effective cancer chemotherapy and avoiding drug-drug interactions.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- Antineoplastic compounds are vital for cancer treatment, with their efficacy influenced by cellular transport proteins.
- Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3 are key liver proteins involved in drug transport.
- Interactions between antineoplastic drugs and these transporters can significantly impact treatment outcomes.
Purpose of the Study:
- To investigate the interactions between commonly used antineoplastic compounds and the OATP1B1 and OATP1B3 transporter proteins.
- To characterize the functional activity of OATP1B1 and OATP1B3 in the context of cancer chemotherapy agents.
- To identify novel interactions that may inform drug development and clinical practice.
Main Methods:
- Functional characterization of OATP1B1 and OATP1B3 in stably transfected human embryonic kidney cells.
- Utilized [(3)H] labeled estrone 3-sulfate and [(3)H] labeled cholecystokinin octapeptide (CCK-8) as substrates for OATP1B1 and OATP1B3, respectively.
- Performed substrate uptake experiments in the presence of various antineoplastic compounds to determine inhibitory effects (Ki values).
Main Results:
- Vinblastine and paclitaxel showed strong interactions with OATP1B1 (Ki values 10.2 μM and 0.84 μM, respectively).
- OATP1B3 exhibited significant interactions with multiple antineoplastic agents, including chlorambucil, mitoxantrone, vinblastine, vincristine, paclitaxel, and etoposide, with Ki values ranging from 1.8 μM to 40.6 μM.
- Several novel interactions between antineoplastic drugs and OATP1B1/OATP1B3 were identified.
Conclusions:
- The study identified significant interactions between OATP1B1 and OATP1B3 with several clinically relevant antineoplastic drugs.
- These findings underscore the importance of considering transporter-drug interactions in cancer chemotherapy.
- Further investigation into the role of OATP1B1 and OATP1B3 is warranted to optimize cancer treatment strategies and manage potential drug-drug interactions.
More Related Videos
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
07:06Isolation of Primary Human Proximal Tubule Epithelial Cells and Their Use in Creating a Microphysiological Model of the Renal Proximal Tubule
Published on: May 9, 2025
Related Concept Videos
ABC Transporters: Exporter
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Elimination by Renal Route: Tubular Secretion
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
